Zealand Pharma Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	239,909 shares
P/E Ratio:	4.19
Forward P/E:	-33.31
EPS:	92.8 DKK
Forward EPS:	-11.68 DKK
Number of Shares:	70,381,800 shares
Market Capitalization:	27,385,559,040.00 DKK

The interactive chart displays the price movement of Zealand Pharma shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company Zealand Pharma does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a strong_buy recommendation for Zealand Pharma stock. The current number of analysts covering this company is 16. The highest target price is 1120 DKK, while the lowest target price is 400 DKK. The median target valuation set by analysts is 850 DKK. These forecasts and recommendations provide insight into how analysts view the future stock performance of Zealand Pharma.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Zealand Pharma stock is: strong_buy
Number of Analysts:	16
Highest Target Price:	1120 DKK
Lowest Target Price:	400 DKK
Median Target Price:	850 DKK

Fundamental Indicators

Indicator	Data
Total Revenue:	9,109,847,040.00 DKK
Net Income:	6,680,927,232.00 DKK
Price-to-Book (P/B):	1.75
PEG Ratio:	/
Exchange:	Copenhagen
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	335
Country:	Denmark

Where to Buy Zealand Pharma Stock?

You can purchase Zealand Pharma stock on the Copenhagen under the ticker symbol: ZEAL.CO. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Zealand Pharma Stock

Indicator	Value
Company Revenue:	9,109,847,040.00 DKK
EBITDA:	7,195,203,072.00 DKK - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	92.8 DKK
Book Value Per Share:	221.77 DKK
Total Cash:	16,577,878,016.00 DKK
Total Cash per Share:	235.54 DKK
Total Debt:	396,952,000.00 DKK
Debt to Equity Ratio:	0.03
Quick Ratio	15.08
Current Ratio	15.09
Free Cash Flow	5,252,183,552.00 DKK
Operating Cash Flow	7,542,714,880.00 DKK
Gross Margins	100.06 %
EBITDA Margins	78.98 %
Operating Margins	91.75 %
Profit Margins	73.34 %
Return on Assets	32.9 %
Return on Equity	53.4 %
Earnings Growth (1 year)	-
Revenue Growth (1 year)	26,527.7 %
Quarterly Earnings Year-over-Year Growth	-
Market Capitalization	27,385,559,040.00 DKK
Enterprise Value	9,923,678,208.00 DKK
EV/Revenue	1.089
EV/EBITDA	1.379
Float Shares	59,883,638 shares
Shares Outstanding	70,381,800 shares
Held Percent Insiders	0.00 %
Held Percent Institutions	59.54 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.55
Short Percentage of Float	-
Implied Shares Outstanding	70,381,800

Frequently Asked Questions (FAQ)

1️⃣ Does Zealand Pharma pay dividends?

According to our data, the company Zealand Pharma does not pay dividends yet, even in 2025.

2️⃣ Where to buy Zealand Pharma shares?

Zealand Pharma shares are traded on the Copenhagen stock exchange under the ticker: ZEAL.CO. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Zealand Pharma shares?

According to our data, the recommendation for Zealand Pharma shares is from a total of 16 analysts. The average target price prediction is 850 DKK per share.

4️⃣ What is the total number of shares and the value of Zealand Pharma on the stock exchange?

The total number of Zealand Pharma shares on the exchange is 70,381,800.00 shares, which at the current market capitalization gives the company a total valuation of 27,385,559,040.00 DKK.